You May Also Like

Hable con su médico acerca de la PrEP
Cite
CITE Title : Hable con su médico acerca de la PrEP Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 4/23/2014 URL : https://stacks.cdc.gov/view/cdc/23417
• File Format:
Copy Export
• RIS
[PDF - 336.70 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
4/23/2014
Description:
Talk to your doctor about PrEP [Spanish]Talk to your doctor about PrEP [español]Usted no tiene el VIH (VIH negativo), pero le preocupa infectarse por...
File Type:
[PDF - 336.70 KB]
File Type:
[PDF - 336.70 KB]

TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts
Cite
CITE Title : TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 8/26/11 URL : https://stacks.cdc.gov/view/cdc/23283
• File Format:
Copy Export
• RIS
[PDF - 98.02 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
8/26/11
Description:
Daily oral PrEP with a tablet containing tenofovir disoproxil fumarate and emtricitabine (TDF/FTC, known by the brand name Truvada®) was found to red...
File Type:
[PDF - 98.02 KB]
File Type:
[PDF - 98.02 KB]